Drug Shortage Report for RATIO-ATORVASTATIN
Report ID | 10883 |
Drug Identification Number | 02350335 |
Brand name | RATIO-ATORVASTATIN |
Common or Proper name | ATORVASTATIN |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ATORVASTATIN |
Strength(s) | 80MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2017-05-17 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2017-10-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2017-09-19 | French | Compare |
v3 | 2017-09-19 | English | Compare |
v2 | 2017-05-23 | French | Compare |
v1 | 2017-05-23 | English | Compare |
Showing 1 to 4 of 4